TrichomeShell News
3 articles
growth-positive
שיח מדיקל: חברת הבת טריכומשל גייסה כ-3 מיליון ש"ח
שיח מדיקל גרופ, the medical cannabis company, has successfully raised approximately 3 million NIS for its subsidiary, TrichomeShell. The funds will be used to establish a production system in the US, as well as for branding and marketing in the CBD market in the US, Europe, and Israel. The company aims to enter the growing CBD market and strengthen its synergy with its subsidiary companies. TrichomeShell specializes in developing and marketing cannabis products, including Moodpick and Power Powder. The successful fundraising reflects the quality and demand for the companys solutions. The CEO of שיח מדיקל גרופ, Yovav Sherid, emphasizes the companys focus on the CBD market in the US, Europe, and Israel. The CEO of TrichomeShell, Guy Shivez, expresses satisfaction with the successful fundraising and the increasing interest in the companys solutions.
InvestmentExpand
growth-positive
https://www.jpost.com/health-science/israeli-smokable-cannabis-sticks-to-hit-us-market-in-january-648430
Israeli start-ups TrichomeShell and StickIt are entering the market with smokable cannabis sticks. TrichomeShells product, called moodpicks, has already entered the Canadian market, while StickIt plans to sell its products in the US, UK, and Europe in January. Both products offer consistent doses of cannabis extracts, addressing the issue of varying compounds in cannabis plants. StickIts sticks have more flexibility in treating different conditions and manipulating flavors and scents. TrichomeShell also offers a water-soluble cannabis powder. Both companies need to complete the international patenting process before expanding further. TrichomeShell and StickIt have the potential for financial success and stability in their respective markets.
CustomersPartners
growth-positive
https://www.jpost.com/health-science/israeli-smokable-cannabis-toothpick-startup-smashes-crowdfunding-goal-645105
Israeli medical cannabis start-up TrichomeShell has raised nearly twice their minimum funding goal in a crowdfunding campaign. They have received nearly NIS 1.3 million in investments with two weeks remaining before the funding deadline. TrichomeShell focuses on cannabis-related innovation and already has two CBD products available for purchase in Europe. The products, called Power Powder and Moodpicks, offer more accurate and measured doses of THC and CBD extracts compared to medical cannabis flower products. TrichomeShell plans to expand to the US and Canadian markets and grow the value of their international patent. The crowdfunding campaign will run until October 22, and they have achieved 197% of their funding goal so far.
InvestmentExpand